EFTA01374085.pdf

AGP LP 519 Alpha Group Capital Paul Barrett Additional Disclaimers Cont'd • References to Specific Companies/Securities. To the extent that this document contains references to specific companies and/or securities, such references are presented solely to illustrate the application of Alkeon's investment process and should not be considered a recommendation of any particular company or security. • Compaisons to Indices. Alkeon believes that, although the Akeon Funds -which include Growth Strategy, Growth Asia Strategy, Capital Partners Strategy and Select Series Strategy - are absolute return vehicles not benChmarked to any index, comparisons to certain indices are useful in evaluating the performance of the Alkeon Funds. The MSCI World Index captures large and mid cap representation across 23 developed markets countries. With 1,652 constituents, the index covers approximately 85% of the free float-adjusted market capitalization in each country. The MSCI AC World Index captures large and mid cop representation across 23 developed markets and 23 emerging markets countries. With 2.491 constituents, the index covers approximately 85% of the global investable equity opportunity set. The Alkeon Funds' portfolios contain equity securities and may consist of securities issued by companies in different countries with vaying capitalizations and fixed income and non-equity investments, including short sales of securities and margin tracing, and ore not as diversified as the securities (when aggregated) that comprise the MSCI World Index or the MSCI AC World Index. Unlike the performance of the Alkeon Funds, the performance of the MSCI World Index and MSCI AC World Index do not reflect the impact of fees or expenses. The index performance shown does not reflect the reinvestment of dividends and other income. Any such comparison between the performance results of the Alkeon Funds and the MSCI World Index and MSCI AC World Index should not be relied upon as an accurate predation of future results. • Sources of Information. Morgan Stanley Fund Services and BNY Mellon provided certain of the performance information shown above. Gross and net exposure estimates are obtained from the Morgan Starley Performance Measurement (MSPM) System. Bloomberg provided the performance data for the indices shown. The information from these sources is believed to be accurate, but Alkeon makes no guarantee as to the accuracy or completeness thereof. • The information provided by Measuriske is the exclusive properly of Measurisk® and is protected by applicable copyright and trademark law and other proprietary rights. UnovIhcrized use of this information is prohibited. You ogee not to copy, reproduce, download, retransmit. disseminate, sell, rent, sublicense, distribute. publish, perform, broadcast, display, circulate or commercially exploit this information In any manner, or alter, store for subsequent use. decompie, disassemble. reverse engineer, or otherwise use this information in whole a in part without the express written consent of Meosuiskit and Alkeon Capital Management, LLC. • Statements Contained in This Document. The statements contained in this document (including those relating to current and future market conditions and trends in respect thereof) that are not historical facts are based upon current expectations, estimates, projections, forecasts, opinions and/or beliefs. Such statements involve known and unknown risks, uncertainties and other factors, and, as a result, reliance should not be placed thereon by investors in making their investments decisions. • Certain Information contained herein may constitute "forword-lookiig statements." which can be identified by the use of terms such as "may," "WIC "should," 'expect," "mticipate," 'forecast," "estimate," "intend," "continue," "target" or "believe" (or the negative thereof) or other variations thereon or comparable terminology. Due to various risks and uncertainties, inducing those discussed above and the risk factors set forth in the Fund's offering documents, actual events a results or actual performance of a fund may differ materially from those reflected or contemplated in such forward-looking statements. As a result, investors should not rely on such forward-looking statements in making Mei investments decisions. • None of the information contained herein has been filed with the U.S. Securities and Exchange Commission, any securities administrator under any securities laws of any U.S. or non-U.S. jurisdiction or any other V.S. or non-U.S. governmental or self-regulatory authority. No such governmental or self-regulatory authority will pass on the merits of the offering of a fund or the adequacy of the information contained herein. Any representation to the contrary is unlawlul. • This document is not an invitation or offer to make an investment in the Fund or my other Alkeon Funds. This document is for information purposes only and the information herein is Incomplete. condensed and waffled in its entirety by the information in the applicable Fund's offering documents. The contents of this document hove not been reviewed or approved by any regulatory body. Page 28 ALKEON CAPITAL MANAGEMENT Private & Confidential CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0068611 CONFIDENTIAL SDNY_GM_00214795 EFTA01374085